Kerala Ayurveda Limited (BOM:530163)
143.30
-4.45 (-3.01%)
At close: Nov 6, 2026
Kerala Ayurveda Revenue
Kerala Ayurveda had revenue of 331.93M INR in the quarter ending June 30, 2026, with 16.01% growth. This brings the company's total for the last twelve months to 1.36B, up 10.09% year-over-year. In the fiscal year ending March 31, 2026, Kerala Ayurveda had annual revenue of 1.31B with 8.99% growth. That makes Kerala Ayurveda the 35,620th largest company in the world by revenue and 2,934th in India.
Revenue (ttm)
1.36B
Revenue Growth
+10.09%
P/S Ratio
1.27
Revenue / Employee
3.28M
Employees
414
Market Cap
1.73B
Revenue by Geography
- India 1.11B 84.5%
- outside India 203.14M 15.5%
Fiscal year ended Mar 31, 2026 See the full Kerala Ayurveda breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.31B | 108.12M | 8.99% |
| Mar 31, 2025 | 1.20B | 171.82M | 16.66% |
| Mar 31, 2024 | 1.03B | 95.28M | 10.18% |
| Mar 31, 2023 | 936.23M | 131.79M | 16.38% |
| Mar 31, 2022 | 804.44M | 183.70M | 29.59% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Bilcare | 8.38B |
| Medico Remedies | 2.38B |
| Sat Kartar Life | 2.24B |
| Gennex Laboratories | 1.78B |
| Lactose (India) | 1.71B |
| Oxygenta Pharmaceutical | 1.35B |
| Accretion Pharmaceuticals | 1.01B |
| Coral Laboratories | 967.01M |